US Patent Issued to OBSIDIAN THERAPEUTICS on June 2 for "CA2-IL15 fusion proteins for tunable regulation" (Massachusetts, Pennsylvania Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,792, issued on June 2, was assigned to OBSIDIAN THERAPEUTICS INC. (Cambridge, Mass.).

"CA2-IL15 fusion proteins for tunable regulation" was invented by Kutlu Goksu Elpek (Arlington, Mass.), Dhruv Kam Sethi (Cambridge, Mass.), Meghan C. Langley (Cambridge, Mass.), Tucker Read Ezell (Cambridge, Mass.), Dexue Sun (Cambridge, Mass.), Jennifer Leah Gori (Jamaica Plain, Mass.), Geetha Hanna Mylvaganam (Boston), Michelle Ols (Northborough, Mass.), Michelle Fleury (Cambridge, Mass.), Celeste Richardson (Brookline, Mass.), James A. Storer (Medford, Mass.), Vipin Suri (Belmont, Mass.), Shyamsundar Subramanian (Downingtown, Pa.), Colleen Foley (Cambridge, Mass.), Molly Reed Perkins (Milton, M...